1. Home
  2. GCT vs NVAX Comparison

GCT vs NVAX Comparison

Compare GCT & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GCT

GigaCloud Technology Inc

HOLD

Current Price

$39.33

Market Cap

1.7B

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$9.40

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GCT
NVAX
Founded
2019
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.3B
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
GCT
NVAX
Price
$39.33
$9.40
Analyst Decision
Strong Buy
Hold
Analyst Count
1
9
Target Price
$33.00
$11.33
AVG Volume (30 Days)
748.0K
4.1M
Earning Date
05-08-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
17.70
309.76
EPS
1.04
N/A
Revenue
$1,161,042,000.00
$1,123,479,000.00
Revenue This Year
$14.43
N/A
Revenue Next Year
$6.78
N/A
P/E Ratio
$38.91
N/A
Revenue Growth
64.96
64.69
52 Week Low
$16.25
$6.20
52 Week High
$51.82
$11.85

Technical Indicators

Market Signals
Indicator
GCT
NVAX
Relative Strength Index (RSI) 39.07 58.07
Support Level $38.42 $9.14
Resistance Level $44.01 $10.42
Average True Range (ATR) 2.77 0.59
MACD -0.79 0.22
Stochastic Oscillator 1.38 53.45

Price Performance

Historical Comparison
GCT
NVAX

About GCT GigaCloud Technology Inc

GigaCloud Technology Inc provides end-to-end and B2B e-commerce solutions for large parcel merchandise. Its B2B e-commerce platform, which is referred to as the GigaCloud Marketplace, integrates everything from discovery, payments, and logistics tools into one easy-to-use platform. It offers online and offline integrated cross-border transaction and delivery services for furniture and large merchandise. Its marketplace seamlessly connects manufacturers in Asia with resellers in the U.S., Asia, and Europe to execute cross-border transactions with confidence, speed, and efficiency. It offers a truly comprehensive solution that transports products from the manufacturer's warehouse to end customers, all at one fixed price. It earns the majority of its revenue from the United States.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: